Renal Cell Carcinoma: A Priority Malignancy for Development and Study of Novel Therapies-Reference-Cited by-同舟云学术

Renal Cell Carcinoma: A Priority Malignancy for Development and Study of Novel Therapies

Published:2003-04-01 Issue:7 Volume:21 Page:1193-1194
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Motzer Robert J.¹

Affiliation:

1. Memorial Sloan-Kettering Cancer Center, New York, NY

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.12.072

Reference16 articles.

1. Phase III Study of Interferon Alfa-NL as Adjuvant Treatment for Resectable Renal Cell Carcinoma: An Eastern Cooperative Oncology Group/Intergroup Trial

2. Porzsolt F: Adjuvant therapy of renal cell cancer with interferon alfa-2a. Proc Am Soc Clin Oncol 11:202,1992, (abstr 622)

3. Pizzocaro G, Piva L, Costa A, et al: Adjuvant interferon to radical nephrectomy in Robson’s stage II and III renal cell cancer: A multicenter randomized study with some biological evaluations. Proc Am Soc Clin Oncol 16:318a,1997, (abstr 1132)

4. Renal-Cell Carcinoma

5. SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendritic Cells or Macrophages? The Microenvironment of Human Clear Cell Renal Cell Carcinoma Imprints a Mosaic Myeloid Subtype Associated with Patient Survival;Cells;2022-10-19

2. A mosaic renal myeloid subtype with T-cell inhibitory and protumoral features is linked to immune escape and survival in clear cell renal cell cancer;2020-01-27

3. Uncommon side effect with a commonly used targeted agent: sunitinib-induced nephrotic syndrome in a patient with metastatic renal cell carcinoma;Case Reports;2014-05-28

4. Prognostic Significance of Histologic Features in Canine Renal Cell Carcinomas;Veterinary Pathology;2014-05-14

5. High Immune Response Rates and Decreased Frequencies of Regulatory T Cells in Metastatic Renal Cell Carcinoma Patients after Tumor Cell Vaccination;MOL MED;2012